Literature DB >> 19703499

A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes.

Flavia Axelband1, Juliana Dias, Filipe Miranda, Fernanda M Ferrão, Nilana M Barros, Adriana K Carmona, Lucienne S Lara, Adalberto Vieyra.   

Abstract

In a previous paper we demonstrated that Ang-(3-4) counteracts inhibition of the Ca(2+)-ATPase by Ang II in the basolateral membranes of kidney proximal tubules cells (BLM). We have now investigated the enzymatic routs by which Ang II is converted to Ang-(3-4). Membrane-bound angiotensin converting enzyme, aminopeptidases and neprilysin were identified using fluorescent substrates. HPLC showed that Plummer's inhibitor but not Z-pro-prolinal blocks Ang II metabolism, suggesting that carboxypeptidase N catalyzes the conversion Ang II--> Ang-(1-7). Different combinations of bestatin, thiorphan, Plummer's inhibitor, Ang II and Ang-(1-5), and use of short proteolysis times, indicate that Ang-(1-7)--> Ang-(1-5)--> Ang-(1-4)--> Ang-(3-4) is a major route. When Ang III was combined with the same inhibitors, the following pathway was demonstrated: Ang III--> Ang IV--> Ang-(3-4). Ca(2+)-ATPase assays with different Ang II concentrations and different peptidase inhibitors confirm the existence of these pathways in BLM and show that a prolyl-carboxypeptidase may be an alternative catalyst for converting Ang II to Ang-(1-7). Overall, we demonstrated that BLM have all the peptidase machinery required to produce Ang-(3-4) in the vicinity of the Ca(2+)-ATPase, enabling a local RAS axis to effect rapid modulation of active Ca(2+) fluxes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703499     DOI: 10.1016/j.regpep.2009.08.004

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

Review 1.  Renin-angiotensin system in the kidney: What is new?

Authors:  Fernanda M Ferrão; Lucienne S Lara; Jennifer Lowe
Journal:  World J Nephrol       Date:  2014-08-06

2.  Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes.

Authors:  Sarfaraz Ahmad; Jasmina Varagic; Brian M Westwood; Mark C Chappell; Carlos M Ferrario
Journal:  PLoS One       Date:  2011-01-10       Impact factor: 3.240

3.  Cardiovascular effects of small peptides of the renin angiotensin system.

Authors:  Patrícia L Moraes; Lucas M Kangussu; Luiz Gonzaga da Silva; Carlos H Castro; Robson A S Santos; Anderson J Ferreira
Journal:  Physiol Rep       Date:  2017-11

Review 4.  Is angiotensin-(3-4) (Val-Tyr), the shortest angiotensin II-derived peptide, opening new vistas on the renin-angiotensin system?

Authors:  Juliana Dias; Flavia Axelband; Lucienne S Lara; Humberto Muzi-Filho; Adalberto Vieyra
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017-01       Impact factor: 1.636

Review 5.  Role of non-classical renin-angiotensin system axis in renal fibrosis.

Authors:  Lin-Li Lv; Bi-Cheng Liu
Journal:  Front Physiol       Date:  2015-04-21       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.